|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Giant magneto resistance-based eddy-current sensor显示文摘 | Teodor Dogaru Smith Stuart T | 2001 | IEEE Transactions on Magnetics2001，37，： | 1 |
| 2 | Adjuvant chemotherapy for radically resected non-small cell lung cancer:A retrospective analysis of 311 consectively treated patients显示文摘 | Teodor H Alin T | 2005 | Lung Cancer2005，47，1： | 1 |
| 3 | The generalized bin packing problem显示文摘 | Mauro M B Teodor G C Guido P Roberto T | 2012 | Transpurtation Research Part E2012，48，6： | 1 |
| 4 | Is latent infection with Toxoplasma gondii a risk factor for suicidal behavior显示文摘 | Teodor T Postolache Thomas Bradley Cook | 2013 | Expert review of anti-infective therapy2013，11，4： | 1 |
| 5 | Novel NO2 gas sensor based on cuprous oxide thin films显示文摘 | SERGIU T SHISHIYANU TEODOR S | 2006 | Sensors and Actuators B2006，113，： | 1 |
| 6 | Selective serotonin reuptake inhibitors: measurement of effect on platelet function 显示文摘 | Donna Jo Mc Closky Teodor T | 2008 | Translational Research2008，151，3： | 1 |
| 7 | Sensing characteristics of tin-doped ZnO thin films as NO2 gas sensor显示文摘 | Sergiu T Shishiyanu Teodor S Shishiyanu | 2005 | Sens Actuat2005，107，： | 1 |
| 8 | Economies of Scale in Empty Freight Car Distribution in Scheduled Railways 显示文摘 | Martin Jobom Teodor Gabriel Crainic Michel Gendreau Kaj Holmberg Jan T Lundgren | 2004 | Transportation Science (S0041-1655)2004，38，2： | 1 |
| 9 | Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge 显示文摘 | Leonardo H Tonelli Teodor T Postolache | 2005 | Neurlogical Research2005，27，7： | 1 |
| 10 | Fault detection and iden- tification with a new feature selection based on mutual informa tion显示文摘 | Sylvain V Teodor T Abdessamad K | 2008 | Journal of Process Control2008，18，5： | 1 |
| 11 | Light treatment for seasonal Winter depression in African-American vs Caucasian outpatients显示文摘AIM: To compare adherence, response, and remission with light treatment in African-American and Caucasian patients with Seasonal Affective Disorder.METHODS: Seventy-eight study participants, agerange 18-64(51 African-Americans and 27 Caucasians)recruited from the Greater Baltimore Metropolitan area, with diagnoses of recurrent mood disorder with seasonal pattern, and confirmed by a Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders-Ⅳ, were enrolled in an open label study of daily bright light treatment. The trial lasted6 wk with flexible dosing of light starting with 10000 lux bright light for 60 min daily in the morning. At the end of six weeks there were 65 completers. Three patients had Bipolar Ⅱ disorder and the remainder had Major depressive disorder. Outcome measures were remission(score ≤ 8) and response(50% reduction)in symptoms on the Structured Interview Guide for the Hamilton Rating Scale for Depression(SIGH-SAD)as well as symptomatic improvement on SIGH-SAD and Beck Depression Inventory-Ⅱ. Adherence was measured using participant daily log. Participant groups were compared using t-tests, chi square, linear and logistic regressions. RESULTS: The study did not find any significant group difference between African-Americans and their Caucasian counterparts in adherence with light treatment as well as in symptomatic improvement.While symptomatic improvement and rate of treatment response were not different between the two groups,African-Americans, after adjustment for age, gender and adherence, achieved a significantly lower remission rate(African-Americans 46.3%; Caucasians 75%; P =0.02).CONCLUSION: This is the first study of light treatment in African-Americans, continuing our previous work reporting a similar frequency but a lower awareness of SAD and its treatment in African-Americans. Similar rates of adherence, symptomatic improvement and treatment response suggest that light treatment is a feasible, acceptable, and beneficial treatment for SAD in African-American patients. These results should lead to intensifying education initiatives to increase awareness of SAD and its treatment in African-American communities to increased SAD treatment engagement.In African-American vs Caucasian SAD patients a remission gap was identified, as reported before with antidepressant medications for non-seasonal depression, demanding sustained efforts to investigate and then address its causes. | Hyacinth N Uzoma Gloria M Reeves Patricia Langenberg Baharak Khabazghazvini Theodora G Balis Mary A Johnson Aamar Sleemi Debra A Scrandis Sarah A Zimmerman Dipika Vaswani Gagan Virk Nijjar Johanna Cabassa Manana Lapidus Kelly J Rohan Teodor T Postolache | 2015 | World Journal of Psychiatry2015，5，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员